Algernon Pharmaceuticals Inc.
AGNPF
$0.06
-$0.003-4.76%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -277.00K | -307.70K | 1.06M | -747.20K | -382.00K |
| Total Depreciation and Amortization | 4.00K | 3.90K | 4.50K | 5.70K | 5.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.40K | 3.40K | -1.36M | 111.80K | 58.50K |
| Change in Net Operating Assets | 82.20K | -161.40K | -1.02M | 451.80K | 279.80K |
| Cash from Operations | -177.40K | -461.90K | -1.31M | -177.90K | -38.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -2.90K | 1.69M | -17.20K | -- |
| Cash from Investing | -- | -2.90K | 1.69M | -17.20K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 200.00 | 341.60K | 7.50K | 265.60K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 286.50K | -- | -- | -- |
| Cash from Financing | 200.00 | 458.60K | 5.50K | 197.70K | -- |
| Foreign Exchange rate Adjustments | 4.00K | -3.50K | 3.30K | -1.00K | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -173.20K | -9.70K | 391.30K | 1.60K | -37.30K |